3 d. ago Caldera launches with $112M, former Morphic CEO and IBD drug from China

Caldera launches with $112M, former Morphic CEO and IBD drug from China  Fierce Biotech

Economics

4 d. ago US moves for AI dominance to outpace China with new ‘overwhelming’ military strategy

America’s top defence official declared that the US must achieve unquestioned AI “dominance” to prevent adversaries from gaining a technological edge, as he unveiled a strategy that includes integrating Elon Musk’s chatbot Grok. Secretary of Defence Pete Hegseth’s announcement did not mention China by name, but it came a month after a report to the US Congress in which the Pentagon warned of Beijing’s accelerating use of AI to reach its military modernisation goals. On Monday, Hegseth said the...

Events

4 d. ago IRENA–ILO Report Finds China Drives Renewable Jobs, Warns of Uneven Global Growth

IRENA–ILO Report Finds China Drives Renewable Jobs, Warns of Uneven Global Growth  The Astana Times

Events

5 d. ago China's Haisco Licenses COPD Drug to AirNexis for Up to USD1.1 Billion

China's Haisco Licenses COPD Drug to AirNexis for Up to USD1.1 Billion  Yicai Global

Events

1 week ago The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs

Hong Kong’s biotech fundraising momentum is expect to extend into 2026, as licensing deals and strong post-initial public offering (IPO) trading last year persuaded investors that China’s drug developers are worth backing again – even before they generate revenue. “Chinese innovation drugs expanding into overseas markets have become the industry mainstream, indicating the domestic innovation sector has entered its harvest phase,” said Felix Huang, head of equity at Oakwise Capital. “New trends...

Economics

2 w. ago China releases 2025 NRDL and first commercial insurance drug list

China releases 2025 NRDL and first commercial insurance drug list  Pharmaceutical Technology

Events

2 w. ago China vital to Insilico’s plan to build biotech’s AI ‘Einstein’ for drug discovery

Biotech firm Insilico Medicine, backed by the Hong Kong Investment Corporation (HKIC), is building a “digital Einstein” to revolutionise how scientists discover new medicines, and plans to continue expanding its research base in China to stay ahead of global rivals after its Hong Kong listing on Tuesday. “Biotechnology is a high-risk field like a ‘molecular casino’,” said founder Alex Zhavoronkov. “Even with artificial intelligence, you can lose 90 per cent of the time.” The 11-year-old company...

Events

3 w. ago Genomic sequencing puts Hong Kong at forefront of cancer care innovation

Genomic sequencing has helped Hong Kong identify the right treatments for cancer patients more quickly, according to an expert who also suggested that the city could be a “super-linker” between mainland China and the rest of the world in drug development. Aya El Helali, a clinician-scientist in medical oncology at the University of Hong Kong, praised how collaboration within the Greater Bay Area had opened up opportunities to run clinical trials faster and at lower costs – factors that appealed...

Politics

3 w. ago China preparing to ‘win a war on Taiwan’ by 2027, new Pentagon report warns

China preparing to ‘win a war on Taiwan’ by 2027, new Pentagon report warns  New York Post

Events

3 w. ago China’s biopharma ascent signals shift in global drug development leadership

China’s biopharma ascent signals shift in global drug development leadership  The Pharma Letter

Politics

3 w. ago The shifting global univeristy landscape: Western decline, Asia rising

The British university system is facing a steep decline, a crisis in the making for over a decade. In the last year, universities have announced over 12,000 job cuts. A report by the Office for Students warns that 40 per cent of England’s universities are facing budget deficits this year, with courses and departments at risk of closure. A great deal of uncertainty has now gripped the university sector. Several factors account for this degradation. Historically, the university sector was funded...

Politics

3 w. ago The shifting global university landscape: Western decline, Asia rising

The British university system is facing a steep decline, a crisis in the making for over a decade. In the last year, universities have announced over 12,000 job cuts. A report by the Office for Students warns that 40 per cent of England’s universities are facing budget deficits this year, with courses and departments at risk of closure. A great deal of uncertainty has now gripped the university sector. Several factors account for this degradation. Historically, the university sector was funded...

Politics

3 w. ago China praises joint effort with US after pair sentenced for drug

China is highlighting its success in joint law enforcement with the sentencing of two men in a drug-related money laundering case following a tip-off from the United States. Amid recent momentum in US-China cooperation to combat narcotics crimes, Chinese state media has outlined the prosecution of the pair who were charged with money laundering for drug dealers. The People’s Daily stated on Saturday that officers in Shenyang, in northeast China’s Liaoning province, had received information in...

Events

3 w. ago China showcases US joint effort after pair sentenced over drugs

China has highlighted its success in joint law enforcement with the US, with state media publishing a rare report on a drugs-related money laundering case triggered by a tip-off from American authorities. Two men were sentenced in September in the case spanning both nations, the People’s Daily reported last week. This comes amid renewed US-China momentum against drug crimes, showcasing steady bilateral progress in anti-narcotics enforcement. Officers in Shenyang, in northeast China’s Liaoning...

Events

4 w. ago Report warns China drug innovation fast gaining ground on US biotech

Report warns China drug innovation fast gaining ground on US biotech  FirstWord Pharma

Events

4 w. ago China’s NMPA Accepts New Drug Application for Tinengotinib Tablets for Advanced Cholangiocarcinoma

China’s NMPA Accepts New Drug Application for Tinengotinib Tablets for Advanced Cholangiocarcinoma  OncLive

Events

4 w. ago China–Cartel Nexus: The Liquidity Architecture Transforming the Global Drug Economy

China–Cartel Nexus: The Liquidity Architecture Transforming the Global Drug Economy  New Lines Institute

Events